I agree that this site is using cookies. You can find further informations here.
X
Calvo, Emiliano
326  results:
?
1

Phase I Trial of Viral Vector-Based Personalized Vaccinatio..:

D'Alise, Anna Morena ; Leoni, Guido ; Cotugno, Gabriella...
Clinical Cancer Research.  30 (2024)  11 - p. 2412-2423 , 2024
Link: https://doi.org/10.1158/..
 
?
2

CEA-CD3 bispecific antibody cibisatamab with or without ate..:

Segal, Neil H. ; Melero, Ignacio ; Moreno, Victor...
Nature Communications.  15 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
3

Pharmacokinetics and Safety of Lurbinectedin Administrated ..:

Moreno, Irene ; Hernández, Tatiana ; Calvo, Emiliano...
Marine Drugs.  22 (2024)  4 - p. 178 , 2024
Link: https://doi.org/10.3390/..
 
?
4

Impact of a Moderate CYP3A4 Inducer (Bosentan) on Lurbinect..:

Moreno, Irene ; Hernández, Tatiana ; Calvo, Emiliano...
Pharmaceuticals.  17 (2024)  2 - p. 182 , 2024
Link: https://doi.org/10.3390/..
 
?
5

Pharmacokinetics (PK) of Tiragolumab in First‐in‐Human Stud..:

Garralda, Elena ; Oh, Do Youn ; Italiano, Antoine...
The Journal of Clinical Pharmacology.  64 (2024)  5 - p. 544-554 , 2024
Link: https://doi.org/10.1002/..
 
?
6

Clinical and Immunologic Characteristics of Colorectal Canc..:

Sanvicente García, Adrián ; Pedregal, Manuel ; Paniagua-Herranz, Lucía...
International Journal of Molecular Sciences.  25 (2024)  10 - p. 5345 , 2024
Link: https://doi.org/10.3390/..
 
?
7

Phase 1b study to assess the safety, tolerability, and clin..:

Stradella, Agostina ; Johnson, Melissa ; Goel, Sanjay...
Cancer Medicine.  13 (2024)  13 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
8

In Silico Transcriptomic Expression of MSR1 in Solid Tumors..:

Sanvicente, Adrián ; Díaz-Tejeiro, Cristina ; Nieto-Jiménez, Cristina...
International Journal of Molecular Sciences.  25 (2024)  7 - p. 3987 , 2024
Link: https://doi.org/10.3390/..
 
?
9

Genomic and Immunologic Correlates in Prostate Cancer with ..:

Paniagua-Herranz, Lucía ; Moreno, Irene ; Nieto-Jiménez, Cristina...
International Journal of Molecular Sciences.  25 (2024)  4 - p. 2222 , 2024
Link: https://doi.org/10.3390/..
 
?
10

MYC targeting by OMO-103 in solid tumors: a phase 1 trial:

Garralda, Elena ; Beaulieu, Marie-Eve ; Moreno, Víctor...
Nature Medicine.  30 (2024)  3 - p. 762-771 , 2024
Link: https://doi.org/10.1038/..
 
?
11

Patient Characteristics Associated with Growth of Patient-D..:

Hernández Guerrero, Tatiana ; Baños, Natalia ; del Puerto Nevado, Laura...
Cancers.  15 (2023)  22 - p. 5402 , 2023
Link: https://doi.org/10.3390/..
 
?
12

Phase 1 first-in-human dose-escalation study of ANV419 in p..:

Joerger, Markus ; Calvo, Emiliano ; Laubli, Heinz...
Journal for ImmunoTherapy of Cancer.  11 (2023)  11 - p. e007784 , 2023
Link: https://doi.org/10.1136/..
 
?
13

Safety and Tolerability of a Novel Anti-HER2 Antibody–Drug ..:

Meric-Bernstam, Funda ; Calvo, Emiliano ; Lee, Keun Seok...
Molecular Cancer Therapeutics.  22 (2023)  10 - p. 1191-1203 , 2023
Link: https://doi.org/10.1158/..
 
?
14

Activity of eftozanermin alfa plus venetoclax in preclinica..:

Tahir, Stephen K. ; Calvo, Emiliano ; Carneiro, Benedito A....
Blood.  141 (2023)  17 - p. 2114-2126 , 2023
Link: https://doi.org/10.1182/..
 
?
15

A Phase 1/2 study of the PD-L1 inhibitor, BGB-A333, alone a..:

Desai, Jayesh ; Fong, Peter ; Moreno, Victor...
British Journal of Cancer.  128 (2023)  8 - p. 1418-1428 , 2023
Link: https://doi.org/10.1038/..
 
1-15